Abstract:The performance of existing immunoassays and bioassays for activins is compromised by the presence of activin-binding proteins such as follistatin and alpha 2 macroglobulin (alpha 2M) in biological fluids. To overcome this problem we have developed a novel two-site enzyme immunoassay procedure for activin-A which incorporates an analyte denaturation and oxidation step. The optimized assay is sensitive (detection limit approximately 10 pg/well), precise (mean within- and between-plate coefficients of variation 4.9 and 9.1% respectively) and accurate (activin-A recovery values of 102 +/- 3 and 96 +/- 5% for bovine follicular fluid (FF) and human serum respectively). In specificity tests, high concentrations of follistatin (500 ng/ml) and alpha 2M (100 microgram/ml) did not interfere with the response signal to activin-A. In addition, no significant cross-reactivity was observed with a range of related molecules including inhibin-A, inhibin-B, activin-B (all < 0.5%), bovine pro-alpha C and follistatin (both < 0.1%). Response curves parallel to the activin-A standard curve were obtained for a variety of test samples including bovine, human, ovine and porcine FF, human sera and conditioned medium from cultured bovine and human granulosa cells. Fractionation of bovine FF by SDS-PAGE confirmed assay specificity since only one peak of activin-A immunoreactivity was detected (M(r) approximately 25 k) in eluted gel slices. However, gel-permeation chromatography showed that under physiological conditions all of the detectable activin-A in bovine FF eluted with apparent M(r) values of > 700 and 60-200 k reflecting its association with binding protein(s). Analysis of bovine FF samples (n = 76) from morphologically dominant follicles during the luteal phase showed that activin-A levels were positively correlated with inhibin-A (r = +0.54; P < 0.001) and total beta subunit immunoreactivity (r = +0.32; P < 0.005) but not with total alpha subunit immunoreactivity (r = -0.09). Classification of these follicles according to oestrogenic status showed that activin-A, inhibin-A and total beta subunit levels were highest in oestrogen-inactive follicles (P < 0.01) whereas total alpha subunit levels were lowest in these follicles (P < 0.001). Activin-A levels were measurable in all human serum samples analysed, ranging from 128 pg/ml during the normal menstrual cycle, 210 pg/ml in women undergoing ovarian hyperstimulation and approximately 500 pg/ml in postmenopausal women to over 4000 pg/ml during pregnancy. In conclusion, the present assay provides a reliable method for quantitating total (i.e. bound+free) activin-A concentrations in a variety of biological samples and should prove useful for further in vivo and in vitro studies in a range of species including man.

Analysis of activin A and follistatin levels in serum from normal and diseased subjects

Diagnostic value of serum activin A and follistatin levels indifferent types of endometriosis

Progress on Inhibin,Activin and Follistatin

Correlative study on the relationship between serum OPG and sRANK and coronary artery lesions in patients with coronary heart disease

Levels of activin A, C-creactive protein and interleukin-6 and the significance in senile patients with coronary heart disease

Serum Activin A Level As a New Maker for the Evaluation of Liver Cirrhosis

The Variation of Serum Activin A Level in Liver Cirrhotic Patients

The relationship between activin A and hepatic fibrosis

Analysis of follistatin levels in sera from patients with abortion

Study of the Application of Serum Follistatin Detection on the Diagnosis of Ovarian Cancer

Association of Serum Follistatin Levels with Histological Types and Progression of Tumor in Human Lung Cancer

Activin A As a Novel Biomarker for Colorectal Adenocarcinoma in Humans.

Identification of activins and follistatin proteins in human follicular fluid and placenta

Relationship Between Follistatin and Liver

Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid

Differences in the Expression of Inhibin Receptors and Activin Receptors in Normal Human Ovaries and Their Significance

Study on Clinical Significance and Serum Levels of Sicam-1 and ACTA in Patients with Chronic Hepatic Disease

Serum activin A as a prognostic biomarker for community acquired pneumonia

Comparison of ELISA and IRMA for follistatin in biological materials

The analysis of serum transforming growth factor-β1 and connective tissue growth factor in chronic heart failure

Relationship between the Level of Serum HA,ACTA,TNF-α and the Pathological Changes of the Liver Tissue in Patients with Chronic Hepatitis